Volume | 533,395 |
|
|||||
News | - | ||||||
Day High | 14.35 | Low High |
|||||
Day Low | 13.53 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Bausch plus Lomb Corporation | BLCO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
14.04 | 13.53 | 14.35 | 13.60 | 13.86 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
5,993 | 533,395 | US$ 13.83 | US$ 7,375,941 | - | 13.16 - 21.95 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 46,261 | US$ 13.60 | USD |
Bausch plus Lomb Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.52B | 350.99M | - | 4.15B | -260M | -0.74 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bausch plus Lomb News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BLCO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 14.80 | 15.15 | 13.16 | 14.01 | 742,931 | -1.54 | -10.41% |
1 Month | 16.12 | 16.55 | 13.16 | 14.55 | 641,043 | -2.86 | -17.74% |
3 Months | 13.91 | 17.695 | 13.16 | 15.47 | 501,166 | -0.65 | -4.67% |
6 Months | 17.41 | 17.695 | 13.16 | 15.42 | 520,648 | -4.15 | -23.84% |
1 Year | 17.45 | 21.95 | 13.16 | 16.88 | 494,725 | -4.19 | -24.01% |
3 Years | 18.50 | 21.95 | 12.20 | 16.42 | 619,209 | -5.24 | -28.32% |
5 Years | 18.50 | 21.95 | 12.20 | 16.42 | 619,209 | -5.24 | -28.32% |
Bausch plus Lomb Description
Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries. |